Endocrine Society — IPEN Guide on EDCs Now Available in Spanish

Last December the Endocrine Society and IPEN, a leading global network of 700 non-governmental organizations (NGOs) working to establish and implement safe chemicals policies and practices, collaborated on the publication of Introduction to Endocrine-Disrupting Chemicals (EDCs): A Guide for Public Interest Organizations and Policy Makers. The purpose of the Guide is to raise global awareness about EDCs and help global policy makers, government leaders, and public interest organizations better understand what EDCs are and the impact EDCs have on human health. Authors of the Guide are Endocrine Society members: Andrea Gore, PhD, David Crews, PhD, Loretta Doan, PhD, Michele La Merrill, PhD, MPH, Health Patisaul, PHD, and Ami Zota, ScD, MS.

We are pleased to announce that the Guide is now available in a Spanish translation. Copies of the Guide in English and Spanish are available online.

The Endocrine Society and IPEN are disseminating the Guide and hope that greater awareness gained by its information will lead to additional programs to enhance knowledge of EDCs, to foster new research into the effects of these chemicals, and to promote a greater appreciation for the critical need for endocrine principles to be applied in formulating EDC policy and regulations.

You may also like

  • Endocrine Society Advocacy Updates

    Endocrine Society Endorses Right to IVF Act  In June 2024, the Endocrine Society endorsed the Right to IVF Act, introduced by Senators Cory Booker (D-NJ), Patty Murray (D-WA), and Tammy Duckworth (D-IL) to protect and expand nationwide access to fertility treatment, including in vitro fertilization (IVF). The Right to IVF Act would help individuals and families…

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

Find more in